Halia Therapeutics raised $0.34 million to develop novel medicines that resolve chronic inflammation and reduce immune-driven damage in neurological and inflammatory diseases.
Halia Therapeutics raised $0.34 million to develop novel medicines that resolve chronic inflammation and reduce immune-driven damage in neurological and inflammatory diseases.
